Lanthanide functionalised gold nanoparticles as MRI contrast agents

The aim of this Ph. D. project was to synthesize and characterise nanoparticle-based MRI contrast agents. In the first instance, the DTPA (diethylenetriaminepentaacetic acid) based ligand was designed, synthesized and characterised. This ligand was utilised for stabilisation of gold nanoparticles. T...

Full description

Bibliographic Details
Main Author: Warsi, Muhammad F.
Other Authors: Chechik, Victor
Published: University of York 2010
Subjects:
Online Access:http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.557163
id ndltd-bl.uk-oai-ethos.bl.uk-557163
record_format oai_dc
spelling ndltd-bl.uk-oai-ethos.bl.uk-5571632017-10-04T03:18:50ZLanthanide functionalised gold nanoparticles as MRI contrast agentsWarsi, Muhammad F.Chechik, Victor2010The aim of this Ph. D. project was to synthesize and characterise nanoparticle-based MRI contrast agents. In the first instance, the DTPA (diethylenetriaminepentaacetic acid) based ligand was designed, synthesized and characterised. This ligand was utilised for stabilisation of gold nanoparticles. The gold nanoparticles protected by DTPA based ligand were characterised using UV-Vis, NMR spectroscopies, TGA and TEM. The nanoparticles were then loaded with gadolinium. The relaxivity of gadolinium loaded gold nanoparticles were studied using inversion recovery method and compared with commercially available MRI contrast agents (i.e. Gd-DTPA). The Gd-loaded AuNPs showed only a moderate increase in their relaxivity as compared to the Gd-DTPA complex. The factors limiting the relaxivity of Gd-loaded AuNPs were explored using EPR spectroscopy. For EPR measurements, Gd3+ was replaced with vanadyl (VO2+) which gives EPR spectra sensitive to the rate of molecular tumbling on nanosecond time scale. The EPR measurements of VO2+-loaded AuNPs showed that the nanoparticle attached metal ion retains high molecular mobility. This is likely responsible for only a moderate increase in relaxivity. We next explored different strategies for increasing the relaxivity of gold nanoparticles based MRI contrast agents. In the first strategy, in order to enhance ligand packing at AuNPs surface, the size of the AuNPs was increased from ~2.0 nm to ~6.0 nm. The relaxivity was found to increase with the increased size of the AuNPs. Secondly, polyelectrolyte coating of charged Gd-loaded AuNPs surface also resulted in increase of relaxivity due to better immobilisation of the Gd3+ ions. Gold nanoparticles were also used as templates for nitroxide based redox sensitive MRI contrast agents. The reducing behaviour and relaxivity of nitroxide protected AuNPs was measured and found slightly better than that of free nitroxide. Finally other useful applications of nanoparticles protected by DTPA based ligand were explored. For example, the DTPA ligand can also chelate strongly with other lanthanides such as Eu3+, Tb3+etc. The luminescence measurements of lanthanides (Eu3+ and Tb3+) loaded onto AuNPs were explored. Lanthanide-loaded AuNPs were also used as model compounds to test an important EPR methodology after labelling with a nitroxide based spin label.615.84University of Yorkhttp://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.557163http://etheses.whiterose.ac.uk/1105/Electronic Thesis or Dissertation
collection NDLTD
sources NDLTD
topic 615.84
spellingShingle 615.84
Warsi, Muhammad F.
Lanthanide functionalised gold nanoparticles as MRI contrast agents
description The aim of this Ph. D. project was to synthesize and characterise nanoparticle-based MRI contrast agents. In the first instance, the DTPA (diethylenetriaminepentaacetic acid) based ligand was designed, synthesized and characterised. This ligand was utilised for stabilisation of gold nanoparticles. The gold nanoparticles protected by DTPA based ligand were characterised using UV-Vis, NMR spectroscopies, TGA and TEM. The nanoparticles were then loaded with gadolinium. The relaxivity of gadolinium loaded gold nanoparticles were studied using inversion recovery method and compared with commercially available MRI contrast agents (i.e. Gd-DTPA). The Gd-loaded AuNPs showed only a moderate increase in their relaxivity as compared to the Gd-DTPA complex. The factors limiting the relaxivity of Gd-loaded AuNPs were explored using EPR spectroscopy. For EPR measurements, Gd3+ was replaced with vanadyl (VO2+) which gives EPR spectra sensitive to the rate of molecular tumbling on nanosecond time scale. The EPR measurements of VO2+-loaded AuNPs showed that the nanoparticle attached metal ion retains high molecular mobility. This is likely responsible for only a moderate increase in relaxivity. We next explored different strategies for increasing the relaxivity of gold nanoparticles based MRI contrast agents. In the first strategy, in order to enhance ligand packing at AuNPs surface, the size of the AuNPs was increased from ~2.0 nm to ~6.0 nm. The relaxivity was found to increase with the increased size of the AuNPs. Secondly, polyelectrolyte coating of charged Gd-loaded AuNPs surface also resulted in increase of relaxivity due to better immobilisation of the Gd3+ ions. Gold nanoparticles were also used as templates for nitroxide based redox sensitive MRI contrast agents. The reducing behaviour and relaxivity of nitroxide protected AuNPs was measured and found slightly better than that of free nitroxide. Finally other useful applications of nanoparticles protected by DTPA based ligand were explored. For example, the DTPA ligand can also chelate strongly with other lanthanides such as Eu3+, Tb3+etc. The luminescence measurements of lanthanides (Eu3+ and Tb3+) loaded onto AuNPs were explored. Lanthanide-loaded AuNPs were also used as model compounds to test an important EPR methodology after labelling with a nitroxide based spin label.
author2 Chechik, Victor
author_facet Chechik, Victor
Warsi, Muhammad F.
author Warsi, Muhammad F.
author_sort Warsi, Muhammad F.
title Lanthanide functionalised gold nanoparticles as MRI contrast agents
title_short Lanthanide functionalised gold nanoparticles as MRI contrast agents
title_full Lanthanide functionalised gold nanoparticles as MRI contrast agents
title_fullStr Lanthanide functionalised gold nanoparticles as MRI contrast agents
title_full_unstemmed Lanthanide functionalised gold nanoparticles as MRI contrast agents
title_sort lanthanide functionalised gold nanoparticles as mri contrast agents
publisher University of York
publishDate 2010
url http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.557163
work_keys_str_mv AT warsimuhammadf lanthanidefunctionalisedgoldnanoparticlesasmricontrastagents
_version_ 1718543067958476800